ARM ARM HOLDINGS PLC /UK
Semiconductors & Related Devices · Nasdaq · SEC CIK 1973239 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY23.8%
TTM net income YoY12.8%
TTM EPS YoY12.8%
Revenue 3-yr CAGR24.4%
Net income 3-yr CAGR73.2%
Margins
Gross margin97.4%
Operating margin16.7%
Net margin17.1%
FCF margin22.2%
EBITDA margin22.1%
Returns
ROE11.3%
ROA8.9%
ROIC (approx.)13.6%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets20.4%
Debt / equity0.00x
Current ratio6.35x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.85x
Accruals ratio-7.6%
Payout ratio—
Capex / revenue9.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $4.92B | $4.01B |
| Cost of revenue | $121.00M | $121.00M |
| Gross profit | $4.80B | $3.89B |
| R&D expense | $2.78B | $2.07B |
| SG&A expense | $1.11B | $984.00M |
| Operating income | $900.00M | $831.00M |
| Pretax income | $1.16B | $720.00M |
| Income tax | $253.00M | -$72.00M |
| Net income | $904.00M | $792.00M |
| EBITDA | $1.15B | $1.01B |
| EPS (basic) | 0.85 | 0.75 |
| EPS (diluted) | 0.85 | 0.75 |
| Weighted avg. shares (diluted) | 1.07B | 1.06B |
| Balance sheet | ||
| Cash & equivalents | $2.75B | $2.08B |
| Short-term investments | $850.00M | $740.00M |
| Receivables | $1.30B | $1.11B |
| Current assets | $6.24B | $4.83B |
| PP&E, net | $772.00M | $354.00M |
| Goodwill | $1.62B | $1.62B |
| Intangibles | $230.00M | $151.00M |
| Total assets | $10.70B | $8.93B |
| Current liabilities | $1.04B | $929.00M |
| Total liabilities | $2.42B | $2.09B |
| Shareholders' equity | $8.29B | $6.84B |
| Shares outstanding | 1.06B | 1.06B |
| Cash flow statement | ||
| Operating cash flow | $1.52B | $397.00M |
| Capital expenditure | $545.00M | $219.00M |
| Free cash flow | $979.00M | $178.00M |
| Investing cash flow | -$325.00M | -$35.00M |
| Financing cash flow | -$548.00M | -$202.00M |
| Depreciation & amortization | $249.00M | $183.00M |
| Stock-based compensation | $1.05B | $820.00M |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.